SAN FRANCISCO — In a landmark settlement agreement, two major pharmaceutical companies and a retailer will pay San Francisco over $267 million in the next 15 years to resolve allegations they were complicit in fueling the city's opioid crisis.
The three companies have agreed to pay a collected $267 million in settlement fees for a 2018 lawsuit, with Walgreens taking the largest share at a whopping $229,610,002. Each of the three settlement agreements mandates a special fund where the proceeds will be deposited, and each will have slightly different eligible use requirements, said City Controller Ben Rosenfield. He added that the city will receive much larger payments in the early years of the settlement.
لقد قمنا بتلخيص هذا الخبر حتى تتمكن من قراءته بسرعة. إذا كنت مهتمًا بالأخبار، يمكنك قراءة النص الكامل هنا. اقرأ أكثر: